Adenoviruses as vaccine vectors

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574

Phenotypic Analysis of Antigen-Specific T Lymphocytes

Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×

Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5

Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt‐Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102

Innate immune recognition: mechanisms and pathways

Medzhitov, R., & Janeway, C. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917309.x · Cited by 1,589

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

Shiver, J. W., Fu, T., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,173

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

Yang, Y., Li, Q., Ertl, H. C. J., & Wilson, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2004-2015.1995 · Cited by 1,033

A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong

TSANG, K. W. T., Ho, P., OOI, G. C., Yee, W. K. S., Wang, T., Chan-Yeung, M. M. W., Lam, W. K., Seto, W., Yam, L. Y.-C., CHEUNG, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,018

CD46 is a cellular receptor for group B adenoviruses

Gaggar, A., Shayakhmetov, D. M., & Lieber, A. (2003) · Nature Medicine · doi:10.1038/nm952 · Cited by 793

Development of a preventive vaccine for Ebola virus infection in primates

Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 655

Adenovirus vaccine

Gaydos, C. A., & Gray, G. C. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3611-1.50043-x · Cited by 3

Adenovirus Transcriptome in Human Cells Infected with ChAdOx1-Vectored Candidate HIV-1 Vaccine Is Dominated by High Levels of Correctly Spliced HIVconsv1&62 Transgene RNA

Matthews, D. A., Milligan, R., Wee, E. G., & Hanke, T. (2023) · Vaccines · doi:10.3390/vaccines11071187 · Cited by 2

A Critical Assessment of COVID-19 Genomic Vaccines

Sabbah, D. A., Hajjo, R., & Sunoqrot, S. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230825094341 · Cited by 4

miRNA-Targeted Vaccines: A Promising Approach for Viral Attenuation and Immunogenicity Enhancement

Debnath, A., Mazumder, R., Mazumder, A., Tripathi, S., Dua, A., Singh, R. K., Mangal, S., Sanchitra, J., Pandey, P., Pal, B., et al. (2024) · Current Gene Therapy · doi:10.2174/0115665232305431240726113347 · Cited by 3

Covalent decoration of adenovirus vector capsids with the carbohydrate epitope αGal does not improve vector immunogenicity, but allows to study the in vivo fate of adenovirus immunocomplexes

Kratzer, R. F., Espenlaub, S., Hoffmeister, A., Kron, M. W., & Kreppel, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176852 · Cited by 3

Viral Vectors for Treatment of Human Disease: Therapeutic and Manufacturing Challenges

Diallo, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814470-1.00007-1 · Cited by 3

Short Communication: Enhancement of Immunogenicity of Replication-Defective Adenovirus-Based Human Immunodeficiency Virus Vaccines in Rhesus Monkeys

Sun, C., Zhang, Y., Liu, Y., Zhang, M., & Chen, L. (2010) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2010.0210 · Cited by 3

Prolongation of prion disease-associated symptomatic phase relates to CD3+ T cell recruitment into the CNS in murine scrapie-infected mice

Sacquin, A., Chaigneau, T., Defaweux, V., Adam, M., Schneider, B., Bruley-Rosset, M., & Éloit, M. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.04.002 · Cited by 3

A potential approach for assessing the quality of human and nonhuman adenoviral vector preparations.

Sayedahmed, E. E., & Mittal, S. K. (2020) · PubMed Central · Cited by 3

Adenovirus DNA Polymerase Loses Fidelity on a Stretch of Eleven Homocytidines during Pre-GMP Vaccine Preparation

Hannoun, Z., Wee, E. G., Crook, A., Colloca, S., Marco, S. D., & Hanke, T. (2022) · Vaccines · doi:10.3390/vaccines10060960 · Cited by 3

Polymeric Vectors for Strategic Delivery of Nucleic Acids

Dunn, A. W., & Shi, D. (2017) · Nano LIFE · doi:10.1142/s1793984417300035 · Cited by 3

Rapid development of optimized recombinant adenoviral vaccines for biosafety level 4 viruses

Sahib, M. M. (2010) · Mspace (University of Manitoba) · Cited by 3

An Ad5‐Based COVID‐19 Vaccine Encoding SARS‐CoV‐2 Spike Glycoprotein Induces Measurable Antibody and Cytokine Responses in Mice

Erendor, F., Üzer, F., & Şanlıoğlu, S. (2026) · Biotechnology Journal · doi:10.1002/biot.70216 · Cited by 2

Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern

Islam, K. U., A-Elgadir, T. M. E., Afaq, S., Ahmad, T., & Iqbal, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.778219 · Cited by 3

Novel and Innovative Approach of Nanotechnology with their Applications in the Management of Infectious Disease, Tuberculosis: An Overview

Singh, S. K., & Ahuja, A. (2022) · Recent Patents on Nanotechnology · doi:10.2174/1872210516666220523122724 · Cited by 2

CRISPR/Cas9 Nano-delivery Approaches for Targeted Gene Therapy

Jacob, E. M., Borah, A., & Kumar, D. S. (2022) · Nanotechnology in the life sciences · doi:10.1007/978-3-031-12658-1_2 · Cited by 3

COVID-19 et vaccins à adénovirus : expérience française de suivi renforcé de pharmacovigilance

Massy, N., Atzenhoffer, M., Boulay, C., Pecquet, P.-E., Ledys, F., Cracowski, J., Masmoudi, K., Lepelley, M., & Gras‐Champel, V. (2023) · Therapies · doi:10.1016/j.therap.2023.01.005 · Cited by 2

A Novel Vaccine Strategy to Prevent Cytauxzoonosis in Domestic Cats

Weerarathne, P., Maker, R., Huang, C., Taylor, B., Cowan, S. R., Hyatt, J., Selvan, M. T., Shatnawi, S., Thomas, J. E., Meinkoth, J. H., et al. (2023) · Vaccines · doi:10.3390/vaccines11030573 · Cited by 2

Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV

Davis, C., Singh, D., Anderson, K. J., Vardeu, A., Kopycinski, J. T., Bridges-Webb, A., Trickett, A., O’Brien, S., Downs, M. E., Kaur, R., et al. (2024) · Vaccines · doi:10.3390/vaccines12060644 · Cited by 2

Is the COVID-19 Pandemic Over? The Current Status of Boosters, Immunosenescence, Long Haul COVID, and Systemic Complications

Ting, M., & Suzuki, J. B. (2022) · International Journal of Translational Medicine · doi:10.3390/ijtm2020021 · Cited by 3

Aspects and issues of marketing authorisation and use of medicinal products for COVID-19 prevention during the pandemic

Алексеевич, С. А., Витальевич, Г. Д., Меркулов, В. А., & Бондарев, В. П. (2022) · Biological Products Prevention Diagnosis Treatment · doi:10.30895/2221-996x-2022-22-4-361-381 · Cited by 2

Efficient adenovirus‐mediated gene transfer to gastric tissue by oral administration

Liu, X., Shi, Y., Zhang, J., Zhuang, Y., Jia, K.-R., Mao, X., Guo, Y., Liu, T., Liu, Z., Wu, C., et al. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1397 · Cited by 2

Adenoviral Vectors Vaccine

Sharma, A., & Worgall, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800276-6.00022-x · Cited by 2

Comparison of Dendritic Cell Activation by Virus-Based Vaccine Delivery Vectors Emphasizes the Transcriptional Downregulation of the Oxidative Phosphorylation Pathway

Tsitoura, E., Kazazi, D., Arslan, D. Ö., Sever, E. A., Khalili, S., Vassilaki, N., Aslanoglou, E., Dérian, N., Six, A., Sezerman, O. U., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.161 · Cited by 2

What’s Hot in HIV in 2019—A Basic and Translational Science Summary for Clinicians From IDWeek 2019

Titanji, B. K., & Kelley, C. F. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa053 · Cited by 2

Adenovirus vaccines

Gray, G. C. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00005-7 · Cited by 2

Common Side Effects of COVID-19 Vaccines Used in Iran: A Review

Siahvoshi, S., Movahed, E., & Ghods, K. (2022) · Annals of Military and Health Sciences Research · doi:10.5812/amh.120362 · Cited by 2

Serotype Specificity of Adenovirus Purification Using Anion- Exchange Chromatography

Konz, J., Livingood, R. C., Bett, A. J., Goerke, A. R., Laska, M. E., & Sagar, S. L. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.ft-137 · Cited by 2

Technologies for Making New Vaccines

Pecetta, S., Ahmed, S., Ellis, R. W., & Rappuoli, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00067-0 · Cited by 2

Emerging Tools for Generating Genomics Data

Jain, K., Pandita, P., Mathuria, A., Mehak, M., Das, D., Saini, A., & Mani, I. (2024) · Springer eBooks · doi:10.1007/978-981-97-3169-5_1 · Cited by 3

Engineered Viruses as Vaccine Platforms

Folgori, A., & Capone, S. (2012) · Springer eBooks · doi:10.1007/978-94-007-4543-8_4 · Cited by 2

Study of Basic Reproduction Number Projection of SARS-CoV-2 Epidemic in USA and Brazil

Severeyn, É., Wong, S., Herrera, H. A., Cruz, A. L., Velásquez, J., & Huerta, M. (2020) · IEEE ANDESCON · doi:10.1109/andescon50619.2020.9272081 · Cited by 2

Adenoviruses

Hidalgo, P., & González, R. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00066-5 · Cited by 2

In vivo tracking of adenoviral-transduced iron oxide-labeled bone marrow-derived dendritic cells using magnetic particle imagingPreprint

Fink, C., Gevaert, J. J., Barrett, J. W., Dikeakos, J. D., Foster, P. J., & Dekaban, G. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.14.532667 · Cited by 2

Bovine Adenovirus-3 Tropism for Bovine Leukocyte Sub-Populations

Khosa, S., Araya, M. B., Griebel, P. J., Arsic, N., & Tikoo, S. K. (2020) · Viruses · doi:10.3390/v12121431 · Cited by 1

Construction and Immunogenicity Evaluation of Recombinant Adenovirus-Expressing Capsid Protein of Foot-and-Mouth Disease Virus Types O and A

Wang, C., Zhang, L., Yu, R., Zhou, P., Zhang, Z., Miao, X., Li, M., Lv, J., Pan, L., Wang, Y., et al. (2023) · Zoonotic Diseases · doi:10.3390/zoonoticdis3020010 · Cited by 1

A replication-incompetent adenoviral vector encoding for HSV-2 gD2 is immunogenic and protective against HSV-2 intravaginal challenge in mice

Rossetti, E., Vujadinovic, M., van Huizen, E., Tolboom, J. T. B. M., Schuitemaker, H., Yao, F., Zahn, R. C., & Saeland, E. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310250 · Cited by 1

Ferritin nanoparticle complex with porcine epidemic diarrhea virus spike protein induces neutralizing antibody response against PEDV in mouse models

Tennakoon, M. S. B. W. T. M. N. S., Park, J., Lee, H., Ryu, J.-H., & Shin, H. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107509 · Cited by 1

Integrated Analytical Techniques to Investigate the Effect of the Freezing/Thawing Cycles on the Non-replicating Recombinant Chimpanzee Adenovirus Viral Vector COVID-19 Vaccine

Mostafa, M. M., AbdelAllah, N. H., Elzanfaly, E. S., & Sedik, G. A. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03220-6 · Cited by 2

Current Status and Challenges of Vaccine Development for Seasonal Human Coronaviruses

Zhang, B., Liu, Y., Chen, T., Lai, J., Liu, S., Liu, X., Zhu, Y., Rao, H., Peng, H., & Ma, X. (2025) · Vaccines · doi:10.3390/vaccines13111168 · Cited by 2

Oncolytic adenoviruses in bladder and kidney cancers: emerging strategies and next frontiers

Yao, J., & Shayakhmetov, D. M. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1729087 · Cited by 1

Engineering chaperone/usher pathway pili for surface display: Structural constraints, design principles, and biotechnological potential

Liu, J., Lian, S., Zhu, C., & Zhu, G. (2026) · Biotechnology Advances · doi:10.1016/j.biotechadv.2026.108865 · Cited by 1

Ebola virus: Ancient virus on a recent outbreak

Remella, R., Japa, A. R., & Remella, S. B. R. (2015) · Research and reviews : journal of pharmacy and pharmaceutical sciences · Cited by 1

Genetic Approaches in Human Embryonic Stem Cells and their Derivatives

Ji, J., Zhong, B., & Bhatia, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385942-6.00025-1 · Cited by 1

Treatment Approach, Pharmacological Agents and Vaccines

Tafoya, Q. J., Watson, V., Pawloski, J., Mohamed, G., & Ramadan, A. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-82691-4.00015-7 · Cited by 1

COVID-19: мифы и реальность

Кордюкова, Л. В., & Shanko, A. V. (2021) · Biochemistry (Moscow) · doi:10.31857/s0320972521070022 · Cited by 1

CRISPR: A Promising Tool for Cancer Therapy

Mohammad‐Rafiei, F., Safdarian, E., Adel, B., Vandchali, N. R., Navashenaq, J. G., & Hayat, S. M. G. (2022) · Current Molecular Medicine · doi:10.2174/1566524022666220624111311 · Cited by 1

Regulated control of virus replication by 4-hydroxytamoxifen-induced splicing

Zhao, Z., Wang, B., Wu, S., Zhang, Z., Chen, Y., Zhang, J., Wang, Y., Zhu, D., Li, Y., Xu, J., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1112580 · Cited by 1

Adenoviral Vector Codifying for TNF as a Co-Adjuvant Therapy against Multi-Drug-Resistant Tuberculosis

Hernández-Bazán, S., Mata‐Espinosa, D., Ramos‐Espinosa, O., Lozano-Ordaz, V., Barrios‐Payán, J., López‐Casillas, F., & Hernández‐Pando, R. (2023) · Microorganisms · doi:10.3390/microorganisms11122934 · Cited by 1

Development of inhaled COVID-19 vaccine and its benefits

Pu, Y. (2024) · International Conference on Biological Engineering and Medical Science (ICBioMed) · doi:10.1117/12.3013000 · Cited by 1

Role of homologous recombination/recombineering on human adenovirus genome engineering: Not the only but the most competent solution

Dawson, L.-M., Alshawabkeh, M., Schröer, K., Arakrak, F., Ehrhardt, A., & Zhang, W. (2024) · Engineering Microbiology · doi:10.1016/j.engmic.2024.100140 · Cited by 1

Assessment of some immunological markers in patients and vaccinated individuals with COVID-19 in Kirkuk city

Tariq, M. J., Noraldeen, M. Y., & Al-kadhi, N. A. (2023) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_171_22 · Cited by 1

Study on the transient expression of infectious bronchitis virus spike protein in Nicotiana benthamiana leaves

Nguyen, T. T., Duong, N. H., Trinh, V. T., My, L. T. T., Hiền, N. T. T., Vân, P. T., Huong, D. T. T., Ngọc, P. B., Hà, C. H., & Hằng, H. T. T. (2024) · Vietnam Journal of Biotechnology · doi:10.15625/1811-4989/19591 · Cited by 1

The Current Progress in the Quest for Vaccines Against the Semliki Forest Virus Complex

Cheong, D. H. J., Yi, B., Wong, Y. H., & Chu, J. J. H. (2025) · Medicinal Research Reviews · doi:10.1002/med.22097 · Cited by 1

Identification of Excipients for Stabilizing Fiberless Adenovirus as Biopharmaceuticals

Kupgan, G., Choudhari, S. P., Flynn, N. H., Nigatu, A. S., Vupputuri, S., Picking, W. L., Picking, W. D., & Ramsey, J. D. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.013 · Cited by 1

Quo vadis en vacunas: desde la aproximación empírica a la nueva oleada tecnológica

Fernández-Prada, M., Trigo, J. A. L., Bayas, J. M., & Cambronero, M. D. R. (2020) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2019.09.001 · Cited by 1

Adverse events and preventive measures related to COVID-19 vaccines

Ahn, T. K., Kang, S. Y., Paik, J. H., & Seo, Y. H. (2021) · Clinical and Experimental Emergency Medicine · doi:10.15441/ceem.21.067 · Cited by 1

Schistosomiasis: Basic requirements for the development of a subunit vaccine, using genetic vectors

Ahmad, G. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104162 · Cited by 1

Viral Technology for Delivery of Nucleic Acids

Bahrami, S., & Pedersen, F. S. (2009) · Wiley eBooks · doi:10.1002/9780470688397.ch5 · Cited by 1

Nucleic Acid Transfer

Schaft, N., Dörrie, J., & Nettelbeck, D. M. (2006) · doi:10.1002/9783527619696.ch55 · Cited by 1

Advances in Quantitative Mass Spectrometry

Wang, M., Han, B., & Wasinger, V. C. (2013) · International Journal of Proteomics · doi:10.1155/2013/621029 · Cited by 1

Rift Valley fever : development of diagnostics and vaccines

Näslund, J. (2010) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1

[Removal and reimplantation of the isolated ureter in the rat].

Saladié, J. M., Blasco, F.-J., Encabo, B., Bayona, S. A. T., Cos, J. M., Noureddine, M. A., & de León, I. P. (1988) · PubMed · Cited by 1

A Binary RNA and DNA Self-Amplifying Platform for Next Generation Vaccines and TherapeuticsPreprint

Jefferies, W. A., Choi, K. B., Ribeca, P., Kari, S., Young, J. B., Hui, E., Qi, S. Y., Garrosvillas, E., Lincez, P. J., Welch, T., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.06.519322 · Cited by 1

Comparison candidate Tick-borne encephalitis virus vaccines based on mRNA, adenovirus serotype 25 and chimera of YFV vaccine strainPreprint

Kuznetsova, N. A., Gushchin, V. А., Marchuk, E. V., Siniavin, A. E., Kleymenov, D. A., Nikiforova, M. A., Zubkova, O. V., Popova, O., Викторовна, В. И., Ozharovskaia, T. A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.16.633390 · Cited by 1

Viral Vectors in Veterinary Vaccine Development

Kumar, A., Pandita, P., Modi, H., Alom, S., & Chavda, V. P. (2025) · Wiley eBooks · doi:10.1002/9781394271566.ch9 · Cited by 1

THE CRITICAL ROLE OF CD4+ TH CELLS IN CD8+ CTL RESPONSES AND ANTI-TUMOR IMMUNITY

Umeshappa, C. S. (2012)

Studies on the immunogenicity in swine of influenza A virus hemagglutinin expressed by Venezuelan equine encephalitis virus-like replicon particles

Crabtree, B. G. (2007) · doi:10.31274/rtd-180813-15988

Multicomponent Vaccine Delivery Systems for Subcellular Targeting of Antigen and Molecular Adjuvant.

Andrews, C. D. (2011)

Consequences of Adenovirus Vector Vaccination on T Cell Activation and SIV Susceptibility in Rhesus Macaques

Brody, I. B. (2014) · Scholarly Commons (University of Pennsylvania)

Improvement of therapeutic vaccination for the treatment of chronic hepatitis B in a preclinical model (woodchuck)

Kosinska, A. D. (2011) · DuEPublico (University of Duisburg-Essen)

Recombinant Adenoviruses for Vaccination

Paolo, N. C. D., Shayakhmetov, D. M., & Lieber, A. (2012) · doi:10.1002/9781118345313.ch15

Lentivector based gene transfer for immunotherapy – application of integration deficient vectors and PDL1knockdown as tools to manipulate immune responses

Karwacz, K. (2012) · UCL Discovery (University College London)

Adenovirus infection is dependent on regulation and accessibility of the receptor CAR

Vincent, C. T. (2007) · Figshare

Preclinical Safety Evaluation of Viral Vaccines

Dempster, A. M., & Haworth, R. (2010) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse190

Dendritic Cell-Based Genetic Immunotherapy for Ovarian Cancer

Mathis, J. M. (2005) · doi:10.21236/ada462730

Genetic Approaches in Human Embryonic Stem Cells and their Derivatives: Prospects for Regenerative Medicine

Ji, J., Zhong, B., & Bhatia, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-381422-7.10009-4

C-JUN N-TERMINAL KINASES REGULATE ADENOVIRUS-MEDIATED AUTOPHAGY AND ANTIGEN PRESENTATION

Klein, S. R. (2013) · Digital Commons-TMC (Texas Medical Center)

Generation and Immunogenicity of a Recombinant Adenovirus Co-Expressing the E2 Protein of Classical Swine Fever Virus and the GP5 Protein of Porcine Reproduction and Respiratory Syndrome Virus

Li, H., Sun, Y., ZHANG, X.-J., CHANG, T.-M., Xiang-peng, W. A. N. G., He, F., Huang, J., & Qiu, H. (2011) · Agricultural Sciences in China · doi:10.1016/s1671-2927(11)60178-8

TẠO ADENOVIRUS TÁI TỔ HỢP MANG ĐOẠN GEN chIL-6

Huyền, V. T. T., Minh, L. H., Cúc, N. T. K., Quyên, V. T., Anh, N. M., Le, T. H., & Cường, P. V. (2015) · Vietnam Journal of Science and Technology · doi:10.15625/0866-708x/53/2/4079

O.018 Therapeutic vaccination in chronic hepatitis B: pre-clinical studies in the woodchuck

Roggendorf, M., & Lu, M. (2006) · Journal of Clinical Virology · doi:10.1016/s1386-6532(06)80027-2

First step in characterization of cis-acting sequences involved in fowl adenovirus 1 (CELO) packaging and its effect on the development of a helper-dependent vector strategy

Barra, C., & Langlois, P. (2008) · Virus Genes · doi:10.1007/s11262-008-0281-6

Adenovirus in Gene Therapy

Montecalvo, A., Gambotto, A. A., & D’Aiuto, L. (2007) · Springer eBooks · doi:10.1007/978-0-387-70909-3_6

MODULATION OF TUMORICIDAL ACTIVITIES OF DENDRITIC CELLS TO ENHANCE ANTIGEN UPTAKE AND CROSS-PRESENTATION

Huang, J. (2005) · D-Scholarship@Pitt (University of Pittsburgh)

GENERATION AND CHARACTERIZATION OF THE CELLULAR IMMUNE RESPONSE TO A CLOSTRIDIUM PERFRINGENS ANTI-SIV MUCOSAL VACCINE

Helmus, R. A. (2008) · D-Scholarship@Pitt (University of Pittsburgh)

Ebola virus: Ancient virus on a recent outbreak

Remella, R., Japa, A. R., & Remella, S. B. R. (2015) · Cited by 1

Vector-based antiviral therapy

Ensser, A. (2006) · Springer eBooks · doi:10.1007/978-0-387-31047-3_19

PERSPECTIVES OF DEVELOPMENT OF LIVE RECOMBINANT ANTHRAX VACCINES BASED ON OPPORTUNISTIC AND APATHOGENIC MICROORGANISMS

Popova, P. Y., & Микшис, Н. И. (2016) · Journal of microbiology epidemiology immunobiology · doi:10.36233/0372-9311-2016-1-79-89

Targeting of adenovirus gene transfer vectors via combined geneti-chemical modification of the minor capsid protein IX

Corjon, S. (2008) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-1481

Advance of Adenoviral Vector in Gene Therapy and Vaccine Research

ZengJun, L., Cao, Y., Liu, Z., & Qing-ge, X. (2006) · Virologica Sinica

cross-reactive antibody to non-human adenovirus vaccine vectors 2

Paris, R., Kuschner, R. A., Binn, L. N., Thomas, S. J., Colloca, S., Nicosia, A., Cortese, R., & Bailer, R. T. (2014)

Genetic Approaches in Human Embryonic Stem Cells and Their Derivatives

Ji, J., Zhong, B., & Bhatia, M. (2008) · Elsevier eBooks · doi:10.1016/b978-012369410-2.50013-9

Adenovirus Evasion of Cell-Intrinsic Immunity

Burrage, A. M. (2016) · Loyola eCommons (Loyola University of Chicago)

The State of T Cell Immunity against Influenza Virus in Humans and Exploration of Potential Strategies to Enhance Cell-Mediated Protection from Influenza Infection

Wagar, L. E. (2013) · TSpace (University of Toronto)

Investigation of a Trimeric Hemagglutinin Stem Domain from Influenza B for a Universal Vaccine

Duran, A. (2018) · uO Research (University of Ottawa) · doi:10.20381/ruor-22454

Transduction of Bovine Peripheral Blood Mononuclear Cells with Recombinant Bovine Adenovirus-3 Expressing Chimeric pIX

Araya, B., & Fragaki, M. (2018) · HARVEST (University of Saskatchewan)

Applications and Implications of Viral and Non Viral Vectors in Gene Therapy

Veerareddy, P. R. (2019) · Open Access Journal of Pharmaceutical Research · doi:10.23880/oajpr-16000176

Secreção de Gaussia luciferase como indicador de atividade de caspase-3/7 em resposta ao tratamento com AdCDKN2AIRESp53 em glioblastoma multiforme.

Oliveira, D. V. C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2019.tde-18022019-101454

Pharmacodynamic Evaluation: Gene Therapy

Grandchamp, N. (2020) · Springer eBooks · doi:10.1007/978-3-319-68864-0_51 · Cited by 1

A review of COVID-19: Molecular basis, diagnosis, therapeutics and prevention

HUYNH, M. T. N., Nguyen, P., PHAN, H. H. C., Phan, N. T. H., LE, K. H., Truong, N. T. H., Le, K. D., HO, D. V., Nguyen, V. T., Tran, H. L. B., et al. (2020) · Science and Technology Development Journal - Natural Sciences · doi:10.32508/stdjns.v4i3.907

Adenovirus Vectors: Excellent Tools for Vaccine Development

Chang, J. (2021) · Immune Network · doi:10.4110/in.2021.21.e6 · Cited by 129

Adenovirus as Tools in Animal Health

Rojas, J. M., Sevilla, N., & Martı́n, V. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.79132 · Cited by 5

Chapter Adenovirus as Tools in Animal Health

Rojas, J. M., Sevilla, N., & Martı́n, V. (2019) · Directory of Open access Books (OAPEN Foundation)

Recombinant Adenoviruses as Vaccines

Randrianarison-Huetz, V., & Perricaudet, M. (1995) · Biologicals · doi:10.1006/biol.1995.0025 · Cited by 75

Adenoviral Vector Immunity: Its Implications and Circumvention Strategies

S. Ahi, Y., S. Bangari, D., & K. Mittal, S. (2011) · Current Gene Therapy · doi:10.2174/156652311796150372 · Cited by 185